Bone Involvement and Osteoporosis in Mastocytosis

被引：63

作者：

Rossini, Maurizio ^{[1
]}

Zanotti, Roberta ^{[1
]}

Viapiana, Ombretta ^{[1
]}

Tripi, Gaia ^{[1
]}

Orsolini, Giovanni ^{[1
]}

Idolazzi, Luca ^{[1
]}

Bonadonna, Patrizia ^{[1
]}

Schena, Donatella ^{[1
]}

Escribano, Luis ^{[1
]}

Adami, Silvano ^{[1
]}

Gatti, Davide ^{[1
]}

机构：

[1] Univ Verona, Policlin Borgo Roma, I-37134 Verona, Italy

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2014年 / 34卷 / 02期

关键词：

Mastocytosis; Osteoporosis; Osteosclerosis; Fracture; Bone mineral density; Bone turnover markers; MAST-CELL DISEASE; SYSTEMIC MASTOCYTOSIS; MARROW MASTOCYTOSIS; RETROSPECTIVE ANALYSIS; HISTAMINE-RECEPTORS; INTERFERON-ALPHA; INDOLENT; OSTEOPENIA; FRACTURE; PAMIDRONATE;

D O I：

10.1016/j.iac.2014.01.011

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Bone involvement is frequent in patients with systemic mastocytosis. Osteoporosis is the most prevalent bone manifestation, but diffuse osteosclerosis or focal osteolytic or osteosclerotic lesions are not infrequent. The risk of osteoporotic fractures is high, especially at the spine and In men. Routine measurements of bone mineral density and vertebral, morphometry are warranted. The bone turnover markers indicate the involvement of complex bone metabolism in mastocytosis-related manifestations.. Bisphosphonates represent the first-line treatment for osteoporosis-related mastocytosis.

引用

页码：383 / +

页数：15

共 50 条

[21] Osteoporosis Caused by Systemic Mastocytosis: Prevalence in a Cohort of 8392 Patients with Osteoporosis
Gehlen, Martin
Schmidt, Niels
Pfeifer, Michael
Balasingam, Subathira
Schwarz-Eywill, Michael
Maier, Anna
Werner, Mathias
Siggelkow, Heide
CALCIFIED TISSUE INTERNATIONAL, 2021, 109 (06) : 685 - 695
[22] Bone Health and Osteoporosis
Lupsa, Beatrice C.
Insogna, Karl
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2015, 44 (03) : 517 - +
[23] Systemic mastocytosis: MRI of bone marrow involvement
M. Roca
J. Mota
P. Giraldo
J. A. García Erce
European Radiology, 1999, 9 : 1094 - 1097
[24] Systemic mastocytosis: MRI of bone marrow involvement
Roca, M
Mota, J
Giraldo, P
Erce, JAG
EUROPEAN RADIOLOGY, 1999, 9 (06) : 1094 - 1097
[25] Fracture Risk Reduction by Bisphosphonates in Mastocytosis?
Onnes, Merel C.
van Doormaal, Jasper J.
van der Veer, Eveline
Versluijs, Joris B.
Arends, Suzanne
Elberink, Hanneke N. G. Oude
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (10) : 3557 - 3564
[26] Dyslipidemia and bone metabolism. A common bond of the osteoporosis and the atherosclerosis?
Yezerska, I
Hernandez, Hernandez J. L.
Martinez, Olmos J. M.
Macias J, Gonzalez
REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2011, 3 (01) : 41 - 49
[27] Multimodal Therapy for Vertebral Involvement of Systemic Mastocytosis
Krueger, Antonio
Hamann, Christine
Brendel, Cornelia
Ramaswamy, Annette
Schnabel, Michael
Neubauer, Andreas
Hofbauer, Lorenz C.
SPINE, 2009, 34 (17) : E626 - E628
[28] Role of sclerostin in mastocytosis bone disease
Szudy-Szczyrek, Aneta
Mlak, Radoslaw
Pigon-Zajac, Dominika
Krupski, Witold
Mazurek, Marcin
Tomczak, Aleksandra
Chromik, Karolina
Gorska, Aleksandra
Kozlik, Pawel
Juda, Adrian
Kokoc, Anna
Dubaj, Maciej
Sacha, Tomasz
Niedoszytko, Marek
Helbig, Grzegorz
Szczyrek, Michal
Szumilo, Justyna
Malecka-Massalska, Teresa
Hus, Marek
SCIENTIFIC REPORTS, 2025, 15 (01):
[29] Systemic mastocytosis: a rare cause of osteoporosis
Garla, Vishnu Vardhan
Chaudhary, Kanooz Ui Qadir
Yaqub, Abid
PAN AFRICAN MEDICAL JOURNAL, 2019, 32
[30] Bone and Cytokine Markers Associated With Bone Disease in Systemic Mastocytosis
Rama, Tiago Azenha
Henriques, Ana Filipa
Matito, Almudena
Jara-Acevedo, Maria
Caldas, Carolina
Mayado, Andrea
Munoz-Gonzalez, Javier I.
Moreira, Andre
Cavaleiro-Rufo, Joao
Garcia-Montero, Andres
Orfao, Alberto
Sanchez-Munoz, Laura
alvarez-Twose, Ivan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (05) : 1536 - 1547

← 1 2 3 4 5 →